Caps and Closures Market

One of the main reasons for choosing elastomeric materials for manufacturing closures is their anti-leaching property and limited interaction potential of the material with the formulation present in vial / syringe. Further, using ready-to-use products saves a lot of time and effort in the overall production processes

-- Project Manager, Business Development, a US based mid-sized company

Caps and Closures Market Overview

The pharmaceutical caps and closures market is estimated to be worth $4.6 billion in 2019 and is expected to grow at CAGR of over 6.7% during the forecast period. Pharmaceutical packaging plays a crucial role in ensuring the sterility and quality of a drug product, while also providing information related to its identity and, in certain cases, dosing instructions. Primary packaging material, owing to the fact that it is in immediate contact with the drug / therapy formulation, is considered to be extremely important when it comes to preserving the stability, efficacy and safety of the packaged drug product. Further, given the growing complexity of modern pharmacological interventions, especially biologics, it has become imperative for drug / therapy packaging considerations to be re-evaluated, taking into consideration the evident shift from large batches of one remedy for everyone to smaller batches of more personalized therapeutic solutions. In addition to optimizing drug-packaging compatibility, stakeholders in the pharmaceutical packaging industry have also adopted a number of other flexible solutions to reduce the overall cost and expedite time to market. 

The use of elastomeric materials, along with various types of coatings (such as FluoroTec^® and Teflon^®), has emerged as a promising alternative to conventional, non-coated closures used for primary packaging containers, which were prone to leaching and shedding of particulate contaminants. The advantages of using elastomeric materials in manufacturing container closures are many, including low leaching potential, minimal chemical interaction with the pharmacological formulation, and the fact that they can be used to make waterproof and airtight closures. Moreover, such closures can also be manufactured in the ready-to-use (RTU) format, which saves a significant amount of time by eliminating the need for multiple steps in the overall fill / finish process. Owing to the aforementioned benefits, the industry has witnessed an evident market growth in preference for elastomeric container closures.

Key Companies in Pharmaceutical Caps and Closures Market 

Examples of key companies engaged in pharmaceutical caps & closures market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Aptar Pharma (a Part of AptarGroup), DWK Life Sciences, West Pharmaceutical Services, Datwyler Sealing Solutions (a Part of Datwyler Group), Lonstroff (a Part of Sumitomo Rubber Industries), Ompi (a Part of Stevanato Group), Daikyo Seiko, Hebei First Rubber Medical Technology and Jiangsu Hualan New Pharmaceutical Material. This market report includes an easily searchable excel database of all the companies providing caps, needle shields, plungers, stoppers, seals, tip caps and other closures for pharmaceutical industry, worldwide.

Scope of the Report

The ‘Pharmaceutical Caps and Closures Market, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures’ market report features a comprehensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunities of the caps and closures market. It features an in-depth analysis, highlighting the various types of elastomeric closures including stoppers, needle shields and plungers, available in the market for various types of primary packaging containers, such as cartridges, syringes and vials.

In addition to other elements, the market research report includes: 

• A detailed assessment of the current market landscape of companies manufacturing elastomeric container closures, featuring information on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible with elastomeric closures, sterilization status of closures (pre-sterilized and unsterilized), affiliated sterilization technique (if the closure(s) is available in the pre-sterilized format), scale of production (small scale, and large scale), type of customization (if available), affiliated dimensions, along with compliance certifications of the product. 
• A comprehensive analysis on the packaging trends of over 230 drug products (including both biologics and small molecule drugs) that were approved over the last five years (beginning 2014), featuring an assessment of the packaging requirements of various container-closure systems based on parameters, such as year of approval of drug, type of molecule, dosage form, route of administration, holding temperature, type of packaging material(s) used for manufacturing primary container and affiliated closure, and leading drug developers (in terms of number of drugs packaged using elastomeric closures). 
• An analysis of various developments / recent trends related to elastomeric packaging materials, offering insights on [A] partnerships and collaborations established within the industry, and [B] recent global conferences related to pharmaceutical packaging industry.
• Elaborate profiles of key players in caps and closures market (shortlisted on the basis of size of product portfolio), featuring a brief overview of the company (including information on company headquarters, year of establishment, number of employees, and key members of the executive team), financial information (if available), detailed description of proprietary elastomeric closures, recent developments, and an informed future outlook.
• A case study on the role of robotics in pharmaceutical manufacturing and fill / finish operations, highlighting the advantages of using automation / automated technologies in such processes. It includes profiles of industry players offering such equipment for the aseptic processing of pharmaceutical products. 
• An elaborate discussion on emerging trends (such as focus on personalized therapies, shift towards more flexible packaging, upgrading packaging components to enhance drug product safety, and growing adoption of smart packaging solutions) that are likely to have an impact on the future adoption of elastomeric container-closure components in the pharmaceutical packaging industry. It also features a Harvey ball analysis, highlighting the relative effect of each trend on the overall pharmaceutical packaging industry.
• An in-depth analysis to estimate the current and future demand for elastomeric closures across key primary packaging containers, including vials, syringes and cartridges, in different regions for the period 2019-2030. Input parameters considered for this analysis include current supply of different primary packaging components and their respective closures and the estimated the proportion of elastomeric closures that are likely to be supplied, which is indicative of the demand. 

The key objective of caps & closures market report is to provide a detailed market analysis in order to estimate the existing caps and closures market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunity for caps and closures market during the forecast period. Based on several parameters, such as target consumer segments, region specific adoption rates and expected prices of such products, we have provided an informed estimate on the likely evolution of the market over the forecast period 2019-2030. The market report provides sales forecasts for the overall elastomeric closure market, wherein both the current and upcoming opportunity is segmented across [A] type of packaging container(s) (vials, syringes and cartridges), [B] type of closure(s) used (seal, stopper, cap, plunger, barrel, and needle shield), [C] sterilization status (pre-sterilized and unsterilized), and [D] key geographies (North America, Europe, Asia-Pacific, and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

The opinions and insights presented in this market report was also influenced by discussions conducted with multiple stakeholders in caps and closures market. The market research report features detailed transcripts of interviews held with the following individuals (in alphabetical order of company names): 

• Julien Maréchal (Business Development and Technology Director, Aseptic Technologies)
• Malcolm Gilmore (Facilitator, BioPhorum Operations Group)
• Marco Pederiva (Marketing and Sales Director, Lonstroff)
• Konstantin Kazarian (Project Manager of Business Development, PYRAMID Laboratories)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.

Frequently Asked Questions

Question 1: What is pharmaceutical packaging?

Answer: Pharmaceutical packaging refers to novel elastomeric materials used for the containment of drugs. These materials are inert in nature and do not react with the enclosed contents.

Question 2: How big is the pharmaceutical caps and closures market?

Answer: The pharmaceutical caps and closures market size is estimated to be worth $4.6 billion in 2019.

Question 3: What is the projected market growth of the pharmaceutical caps and closures market?

Answer: The pharmaceutical caps and closures market is expected to grow at compounded annual growth rate (CAGR) of over 6.7% during the forecast period 2019 - 2030.

Question 4: Who are the leading companies in the pharmaceutical caps and closures market?

Answer: Examples of key companies engaged in pharmaceutical caps and closures market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Aptar Pharma (a Part of AptarGroup), DWK Life Sciences, West Pharmaceutical Services, Datwyler Sealing Solutions (a Part of Datwyler Group), Lonstroff (a Part of Sumitomo Rubber Industries), Ompi (a Part of Stevanato Group), Daikyo Seiko, Hebei First Rubber Medical Technology and Jiangsu Hualan New Pharmaceutical Material.

Question 5: How many unique materials are currently used by the companies engaged in pharmaceutical caps and closures market?

Answer: Currently, over 20 unique materials are currently used by the players engaged in pharmaceutical packaging market for the fabrication of various types of closure systems.

Question 6: How many elastomeric closures are currently manufactured by the companies engaged in pharmaceutical packaging market?

Answer: More than 240 elastomeric closures are currently manufactured by the players engaged in pharmaceutical caps and closures market.